Quantitation of nitrofurantoin in human plasma by liquid chromatography tandem mass spectrometry

1. D. R. Guay, An update on the role of nitrofurans in the management of urinary tract infections, Drugs 61 (2001) 353-364.10.2165/00003495-200161030-00004Search in Google Scholar

2. D. C. Hooper, Urinary Tract Agents: Nitrofurantoin and Methenamine, in Principles and Practice ofInfectious Diseases (Eds. G. L. Mandell, J. E. Bennet and R. Dolin), Elsevier Churchill Livingstone Inc., Philadelphia 2009, pp. 515-520.10.1016/B978-0-443-06839-3.00037-0Search in Google Scholar

3. M. Maaland, and L. Guardabassi, In vitro antimicrobial activity of nitrofurantoin against Escherichiacoli and Staphylococcus pseudintermedius isolated from dogs and cats, Vet. Microbiol. 151 (2011) 396-399; DOI: 10.1016/j.vetmic.2011.03.009.10.1016/j.vetmic.2011.03.009Search in Google Scholar

4. AHFS Drug Information (Ed. G. K. Mcevoy), American Society of Hospital Pharmacists, Betuerda (MD) 1990, p. 438.Search in Google Scholar

5. A. Bains, D. Buna and N. A. Hoag, A retrospective review assessing the efficacy and safety of nitrofurantoin in renal impairment, Can. Pharm. J. 142 (2009) 248-252; DOI: 10.3821/1913 -701X- -142.5.248.Search in Google Scholar

6. W. A. Petri, Sulfonamides, trimethoprim, sulfamethoxazole, quinolones, and agents for urinary tract infections, in Goodman & Gilman’s Pharmacological Basis of Therapeutics (Eds. L. L. Brunton, J. S. Lazo and K. L. Parker), McGraw Hill, New York, 2006, pp. 1111-1125.Search in Google Scholar

7. M. Khodari, H. Mansour, H. S. El-Din and G. Mersal, Cathodic stripping voltammetry of the antibacterial drug (nitrofurantoin), Anal. Lett. 31 (1998) 251-262; DOI: 10.1080/00032719 808002043.Search in Google Scholar

8. E. Hammam, Determination of nitrofurantoin drug in pharmaceutical formulation and biological fluids by square-wave cathodic adsorptive stripping voltammetry, J. Pharm. Biomed. Anal. 30 (2002) 651-659; DOI: 10.1016/S0731-7085(02)00344-8.10.1016/S0731-7085(02)00344-8Search in Google Scholar

9. V. Arancibia, M. Valderrama, A. Madariaga, M. C. Zúñiga and R. Segura, Extraction of nitrofurantoin and its toxic metabolite from urine by supercritical fluids. Quantitation by high performance liquid chromatography with UV detection, Talanta 61 (2003) 377-383; DOI: 10.1016/ S0039-9140(03)00276-5.10.1016/S0039-9140(03)00276-5Search in Google Scholar

10. P. Muth, R. Metz, B. Siems, W. W. Bolten and H. Vergin, Sensitive determination of nitrofurantoin in human plasma and urine by high-performance liquid chromatography, J. Chromatogr. A729 (1996) 251-258; DOI: 10.1016/0021-9673(95)00894-2.10.1016/0021-9673(95)00894-2Search in Google Scholar

11. F. W. Kari, R. Weaver and M. C. Neville, Active transport of nitrofurantoin across the mammary epithelium in vivo, J. Pharmacol. Exp. Ther. 280 (1997) 664-668; DOI: 0022-3565/97/2802-0664.Search in Google Scholar

12. G. Merino, J. W. Jonker, E. Wagenaar, A. E. van Herwaarden and A. H. Schinkel, The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin, Mol. Pharmacol. 67 (2005) 1758-1764; DOI: 10.1124/ mol.104.010439.10.1124/mol.104.010439Search in Google Scholar

13. K. K. Adkison, S. S. Vaidya, D. Y. Lee, S. H. Koo, L. Li, A. A. Mehta, A. S. Gross, J. W. Polli, Y. Lou and E. J. Lee, The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects, Br. J. Clin. Pharmacol. 66 (2008) 233-239; DOI: 10.1111/j.1365-2125.2008.03184.x.10.1111/j.1365-2125.2008.03184.xSearch in Google Scholar

14. R. S. Patil, K. A. Chaitanya, P. V. D. L. S. Ravi Prakash and S. R. Patil, Simple, rapid and sensitive method for determination of nitrofurantoin in human plasma by using liquid chromatography/ tandem mass spectrometry, Curr. Trends Biotechnol. Pharm. 6 (2012) 196-203.Search in Google Scholar

15. US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research, Guidance for Industry, Bioanalytical Method Validation, CDER, Centre for Veterinary Medicine (CVM), Rockville (MD) 2001.Search in Google Scholar

16. B. K. Matuszewski, M. L. Constanzer and C. M. Chavez-Eng, Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS, Anal. Chem. 75 (2003) 3019-3030; DOI: 10.1021/ac020361s.10.1021/ac020361sSearch in Google Scholar

17. R. King, R. Bonfiglio, C. Fernandez-Metzler, C. Miller-Stein and T Olah, Mechanistic investigation of ionization suppression in electrospray ionization, J. Am. Soc. Mass Spectrom. 11 (2000) 942-950; DOI: 10.1016/S1044-0305(00)00163-X.10.1016/S1044-0305(00)00163-XSearch in Google Scholar

18. M. Yadav, and P. S. Shrivastav, Incurred sample reanalysis: A decisive tool in bioanalytical research, Bioanalysis 3 (2011) 1007-1024; DOI: 10.4155/bio.11.76. 10.4155/bio.11.7621545349Search in Google Scholar